Government of Argentina Report issue

Government Phase 1 Phase 2 Phase 3 Phase 4
Founded: Argentina (1994)

Organization Overview

First Clinical Trial
2011
NCT01329757
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Agencia Nacional de Promoción Científica y Tecnológica, Argentina | INPB - ANLIS Malbrán | Maria de los Angeles Peral de Bruno | Ministerio de Salud de Ciudad Autónoma de Buenos Aires | Ministerio de Salud y Politicas Sociales (Ministry of Health) | Ministery of Health, Tucumán, Argentina | Ministry of Health, Tucuman, Argentina | Ministry of Public Health, Argentina | Ministry of Public Health, Tucumán, Argentina | Ministry of Science and Technology, Argentina | Minsterio de Salud de la Nacion, Argentina

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Melanoma (Phase 1)

Rubella (Phase 4)

Spinal Cord Injuries (Phase 3)

Suicide (Phase 1)

Wounds and Injuries (Phase 3)

Yellow Fever (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 14
  • # of Trial APIs: 21